Lazard Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $205M 4.9M 41.94

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc A Common Stock (GOOGL)
Intercontinen Common Stock (ICE)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Unitedhealth Gr Common Stock (UNH)
Accenture Common Stock (ACN)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Exelon Corp Common Stock (EXC)
Aon Plc/ireland Common Stock (AON)
Exxon Mobil Common Stock (XOM)
Broadcom Common Stock (AVGO)

View all positions for Lazard Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated